Intellectual Asset Management Lists Rothwell Figg as One of the “World’s Leading Life Science Patent Litigation Law Firms”

Based on feedback from peers and clients in the field and follow-up research and interviews, Intellectual Asset Management (IAM) lists Rothwell Figg as one of the "world’s leading life science patent litigation law firms." In its May/June 2010 edition, IAM recommends Rothwell Figg for its expertise in biotech and pharmaceutical fields as well as its solid background in generic patent infringement cases. Further, in its newly published book, IAM LIFE SCIENCES 250, IAM lists E. Anthony Figg as one of the top eleven "US Best of the Best" life sciences IP practitioners. According to clients and peers surveyed, Tony Figg was particularly singled out "for his abbreviated new drug application (ANDA) and general pharmaceutical patent litigation expertise." Additionally, Mr. Figg was highlighted among the top three Washington, DC-based attorneys as "a very experienced litigator particularly on the generic side of Hatch-Waxman cases."

FULL ARTICLE: http://www.iam-magazine.com/blog/detail.aspx?g=0559d9c7-b166-4561-879c-6e608586bc99&q=leading+life+science+patent+law+firms#search=%22leading+life+science+patent+law+firms%22